Scoop: Cor­po­rate de­vel­op­ment chief hits the ex­it at Bio­gen as ad­u­canum­ab jit­ters roll on

Michel Vounatsos has lost an­oth­er mem­ber of his ex­ec­u­tive team.

Less than 2 years af­ter Daniel Karp was hired on as the EVP of cor­po­rate de­vel­op­ment — where he ran the strat­e­gy and BD teams — he’s now hit­ting the ex­it as the com­pa­ny finds it­self at a mo­men­tous cross­roads.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER